Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
Serina Therapeutics, Inc.US flagNew York Stock Exchange American
1.79
USD
+0.03
- -
19.39MMarket Cap

Serina Therapeutics, Inc. (SER) Stock Splits

Learn about Serina Therapeutics, Inc.'s most recent 7-for-250 basis stock split on March 15, 2024. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Serina Therapeutics, Inc.'s most recent stock split

Split Date: 2024-03-15
Split Ratio: 7:250
Price Before Split: $0.62
Price After Split: $0.02

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 35.71 times fewer shares (a 7:250 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Serina Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-03-157:250Yes$0.62$0.02

About Serina Therapeutics, Inc.

Company overview and industry information

Serina Therapeutics, Inc. (SER) operates in the Biotechnology industry. The recent 7-for-250 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Serina Therapeutics, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.